How Retatrutide May Work How Triple Agonist Weight Loss Research Works Retatrutide is being studied because it combines three metabolic pathways that may work together: In phase 3 clinical trials, Lilly is evaluating Retatrutide across several obesity and weight-related health conditions, including obesity, overweight with weight-related medical problems, type 2 diabetes, sleep apnea, knee osteoarthritis, cardiovascular and renal outcomes, and liver-related metabolic disease
Yeo, Yee Hui, et al
But since losing the weight, my social anxiety has lessened, she explains
If youre struggling with alcohol, you dont have to wait for the next breakthrough to get help
To view or add a comment, sign in Explore related topics Explore content categories
[7] Because retatrutide is an IMP, the storage conditions that apply to any given supply will be specified on the IMP label and in the clinical trial protocol or named-patient supply documentation